Answers are grounded in this paper and cite their sources.
roprotein convertase subtilisin/kexin type 9 (PCSK9) is a low-abundance plasma protein that promotes the degradation of the lowdensity lipoprotein (LDL) receptor (LDLR), thus
No takes yet. Share an insight, caveat, or question.
Pamir et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: